Rapid Death Rate Found in Children Shortly After Receiving Dengvaxia Vaccine
Forensic investigators confirm vaccines linked to death within 6 months
A team of leading forensic investigators has found a direct link between the Dengvaxia vaccine and a "rapid death rate" in Children.
Forensic expert Dr. Erwin Erfe, director of the Public Attorney’s Office (PAO) Forensic Laboratory, confirmed on Wednesday that children who got sick within 6 months on receiving the vaccine, had died shortly after.
Dr. Erfe said death would follow "very fast" and was a "cause of the disease" resulting from the vaccination.
One child, 11-year-old Zandro Colite, who died last Dec. 27, died less than 24 hours after feeling the symptoms of severe dengue, according to Erfe.
“Less than 24 hours after he first felt fever, headache ... dead child,” the doctor told radio dzMM.
According to Inquirer, Erfe examined the child’s body on Jan. 9 and found that the boy suffered “massive bleeding” in his brain, lungs, heart, kidneys, and liver. He also had enlarged kidneys and spleen.
Colite received a total of three doses of the Dengvaxia vaccine within six months.
Dr. Erfe said that upon examining the four bodies of the children inoculated with Dengvaxia, they found that they fell ill within the six month period after receiving the vaccine aimed at fighting dengue.
He noted a “pattern” that showed the rapid progression of illness among the children who died after getting sick within six months from vaccination.
“Within the six month period, very fast because of the disease,” he said.
Erfe said he had prayed that they would not find a pattern in the deaths of the children. Unfortunately, he said, a pattern is emerging.
Major Investigation Launched
On Thursday, authorities in Bataan, Philippines, exhumed the body of an 11-year-old student who died of dengue 11 days after receiving the Dengvaxia vaccine.
GMA reports: The forensics team of the Public Attorney's Office went to Bagac, Bataan to exhume the remains of 11-year-old John Paul Rafael and subject them to forensic examination, according to a report on News To Go by Chino Gaston.
PAO will also exhume the remains of another student who likewise died of dengue.
The forensics team, however, had difficulty checking if there was massive bleeding in Rafael's internal organs since it has been almost two years since the boy passed away in April 2016.
Massive bleeding and inflammation of internal organs were detected in the remains of five other dengue victims who were vaccinated with Dengvaxia.
PAO forensics chief Dr. Erwin Erfe, however, said they discovered staining in the skull of Rafael, which may indicate that bleeding occurred prior to death.
The team retrieved tissue samples for further examination in a laboratory.
Cristina Ramirez, an aunt of Rafael, said the family decided to allow the exhumation to determine the cause of the boy's death.
One of the causes of death given, she said, was congenital heart disease, said to be a preexisting condition of the boy.
Rafael exhibited the same symptoms as the other victims who died of dengue—stomachache, lethargy, and bleeding.
His family wants those behind the vaccination drive to be held accountable.
They also hope Rafael's case will serve as a warning to other parents whose children also received the Dengvaxia vaccine.
PAO already exhumed the remains of three other children — Anjielica Pestilos, 10, Zandro Colite, 11, and Lenard Baldonado, 10 — who died of dengue sometime after they received Dengvaxia.
Erfe said a pattern was found on the illnesses suffered by the children before they died, including bleeding in various internal organs and enlarged organs.
A separate expert panel of doctors from the University of the Philippines-Philippine General Hospital was tasked to review the cases of children who died after receiving Dengvaxia to see if the deaths were related to the vaccine.
Dengvaxia manufacturer Sanofi Pasteur admitted in November 2017 that individuals who have not contracted dengue prior to inoculation of the anti-dengue vaccine may develop a severe disease in the future.
The Department of Health stopped the dengue immunization program after Sanofi made the disclosure.
In addition to this, the Food and Drug Administration (FDA) imposed administrative sanctions on Sanofi Pasteur, ordered the certificate of product registration of dengue vaccine Dengvaxia suspended and fined the company P100,000.
The DOH estimated that more than 830,000 children, aged nine and above, from public schools in Metro Manila, Central Luzon, Calabarzon, and Cebu were vaccinated with Dengvaxia.